News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2024 Shelley Wood April 30, 2024
News Conference News ACC 2024 Vaping Linked to Higher Risk of HFpEF, NIH Data Show L.A. McKeown April 12, 2024
Presentation ACC 2024 A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy Presenter: James L. Januzzi Jr April 08, 2024
News Conference News ACC 2024 STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed L.A. McKeown April 06, 2024
Presentation ACC 2024 Main Results From The Step-hfpef Dm Trial Presenter: Mikhail Kosiborod April 06, 2024
News Conference News ACC 2024 Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI Shelley Wood April 06, 2024
News Daily News Cognitive Impairment a Real Concern in HF Patients: HFSA Caitlin E. Cox March 13, 2024
News Daily News How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs? Caitlin E. Cox March 07, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News Living Near Bars, Restaurants Linked to Greater Likelihood of HF L.A. McKeown February 29, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023